hsa-miR-425-5p

ncRNA information

ncRNA name

hsa-miR-425-5p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

SIRT1

Cancer information

Cancer name

Liver Cancer

Cancer site

None

Treatment information

Treatment type

Chemotherapy

Drug

Sorafenib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cance

Tissue resource

lung cancer cell lines HepG2

lung cancer cell lines Hep3B

lung cancer cell lines PLC

lung cancer cell lines MIHA

Experiment

None


Institute

CoBioer Biosciences Co Ltd

Hunan Fenghui Biotechnology Co Ltd

Country

Continent